Medical Device News Magazine

Pascal Groenen Appointed COO at BeVinced | Proven Leadership Track Record

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Pascal Groenen

BeVinced, a leading innovator in the Medtech CRO business is delighted to announce the appointment of Pascal Groenen as its new Chief Operating Officer (COO).

Experience

Pascal Groenen brings a wealth of experience and a proven track record of success in his previous leadership roles in the Medtech CRO business, making him a valuable addition to the BeVinced team. This extensive background has equipped him with a deep understanding of the industry and the challenges and opportunities it presents.

Pascal demonstrated exceptional leadership, consistently driving growth and innovation. His strategic vision, operational excellence, and commitment to delivering results have earned him a reputation for excellence in the field.

As BeVinced’s new COO, Pascal will play a pivotal role in shaping the company’s future growth and development. His leadership and expertise will be instrumental in driving  strategic initiatives, streamlining operations, and ensuring that BeVinced continues to provide the highest level of service and innovation to its clients.

“We are thrilled to welcome Pascal Groenen to the BeVinced team,” said Dirk Meijer CEO & Founder of Bevinced. “His impressive accomplishments in our industry and his proven ability to lead and execute strategic initiatives make him the ideal choice for our COO position. We look forward to working closely with Pascal to achieve new levels of success for BeVinced.”

Joris Bannenberg, CMO & Founder, said…

Pascal Groenen’s appointment as COO represents a significant milestone for BeVinced. In addition to his proven track record, his outstanding personality and team-player spirit will ensure that he plays a pivotal role in forming and leading our team, thereby contributing significantly to the success and growth of BeVinced.”

Pascal Groenen Replied

Pascal Groenen expressed his enthusiasm for the new role, saying, “I am excited to join BeVinced and contribute to its continued growth and success. I believe in the company’s vision and its commitment to excellence, and I look forward to collaborating with the talented BeVinced team.”

BeVinced is confident that Pascal Groenen’s appointment as COO will further strengthen the company’s position as a leader in Medtech service industry for market approvals of Medical Devices and enhance its ability to deliver exceptional value to clients.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”